Endothelium and cannabinoid receptor involvement in levcromakalim vasorelaxation

European Journal of Pharmacology

Volumn 339, Issue 2-3, 1997, Pages 157-160

  White, Richard ^a   Hiley, C Robin ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cannabinoid receptor; Endothelium; Levcromakalim

Indexed keywords

APAMIN; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CARBACHOL; CHARYBDOTOXIN; LEMAKALIM; METHOXAMINE; N ACETYL S NITROSOPENICILLAMINE; PINACIDIL; POTASSIUM CHANNEL STIMULATING AGENT; RIMONABANT;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; CROMAKALIM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GUANIDINES; MALE; MESENTERIC ARTERIES; PINACIDIL; PIPERIDINES; POTASSIUM CHANNELS; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; VASODILATION; VASODILATOR AGENTS;

EID: 0031588371     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01397-6     Document Type: Article

References (12)

1. +: A functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J. Cardiovasc. Pharmacol. 21:1993;423-429.
2. +-channel blockers on ACh-induced hyperpolarization and relaxation in mesenteric arteries. Am. J. Physiol. 272:1997;H2306-H2312.
3. Garland C.J., McPherson G.A. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br. J. Pharmacol. 105:1992;429-435.
4. - currents in human vascular endothelial cells: Role of ionic currents in stimulation of nitric oxide biosynthesis. Circ. Res. 75:1994;304-314.
5. Katnik C., Adams D.J. Characterization of ATP-sensitive potassium channels in freshly dissociated rabbit aortic endothelial cells. Am. J. Physiol. 272:1997;H2507-H2511.
6. McCulloch A.I., Randall M.D. Modulation of vasorelaxant responses to potassium channel openers by basal nitric oxide in the rat isolated superior mesenteric arterial bed. Br. J. Pharmacol. 117:1996;859-866.
7. McCulloch A.I., Bottrill F.E., Randall M.D., Hiley C.R. Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br. J. Pharmacol. 120:1997;1431-1438.
8. Randall M.D., Alexander S.P.H., Bennett T., Boyd E.A., Fry J.R., Gardiner S.M., Kemp P.A., McCulloch A.I., Kendall D.A. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Commun. 229:1996;114-120.
9. 2): Identification of cannabinoid receptor subtype selective ligands. J. Pharm. Exp. Ther. 278:1996;989-999.
10. White R., Hiley C.R. Comparison of the vasorelaxation caused by endothelium-derived hyperpolarising factor (EDHF) and anandamide in the rat small mesenteric artery of the rat. Br. J. Pharmacol. 122:1997;23P.
11. Zygmunt P.M., Högestätt E.D. Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br. J. Pharmacol. 117:1996;1600-1606.
12. Zygmunt P.M., Edwards G., Weston A.H., Davis S.C., Högestätt E.D. Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery. Br. J. Pharmacol. 118:1996;1147-1152.